News Takeda could sell Shire eye care business after merger Takeda could be considering selling Shire’s eye care business after their $62 billion merger next year to cut debts, according to press reports.
News UK pharma has concerns about the new NHS 10-year plan The ABPI is worried about investment in medicines and moves that could limit patient and doctor treatment choice in the NHS 10-year plan.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face